logo
Home  > sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate

AA20528

115436-72-1 | sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate

Packsize Purity Availability Price Discounted Price    Quantity
25mg 98% in stock $15.00 $10.00 -   +
100mg 98% in stock $18.00 $12.00 -   +
250mg 98% in stock $22.00 $15.00 -   +
1g 98% in stock $40.00 $28.00 -   +
5g 98% in stock $105.00 $74.00 -   +
25g 98% in stock $386.00 $270.00 -   +

*All products are for research use only and not intended for human or animal use.

*All prices are in USD.

Request Bulk Quote
Description
Catalog Number: AA20528
Chemical Name: sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate
CAS Number: 115436-72-1
Molecular Formula: C7H10NNaO7P2
Molecular Weight: 305.0941
MDL Number: MFCD14584874
SMILES: OC(P(=O)(O)O)(P(=O)(O)[O-])Cc1cccnc1.[Na+]

 

Computed Properties
Complexity: 375  
Covalently-Bonded Unit Count: 2  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 8  
Hydrogen Bond Donor Count: 4  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 1  

 

 

Upstream Synthesis Route 
  • Risedronate sodium is a valuable compound in chemical synthesis due to its ability to inhibit bone resorption. This pharmaceutical agent plays a crucial role in the treatment of osteoporosis and other bone-related conditions by effectively targeting osteoclasts, the cells responsible for breaking down bone tissue. In chemical synthesis, risedronate sodium is commonly utilized for the development of novel drug compounds that require bone-targeting properties. Its unique mechanism of action makes it a versatile tool in designing therapeutic agents for bone disorders. Additionally, risedronate sodium's pharmacological profile and stability make it a preferred choice for researchers and pharmaceutical companies seeking to create innovative treatments for osteoporosis and related diseases.
Literature
FEATURED PRODUCTS